Lannett Company, Inc.

Form 483 issued February 2, 2018 · Seymour, Indiana

Inspection
Jan 29 – Feb 2, 2018
Observations
2
Pages
4
FEI number
1819171

In short: On February 2, 2018, FDA issued a Form 483 with 2 observations to Lannett Company, Inc. in Seymour, Indiana (FEI 1819171) after an inspection that ran Jan 29 – Feb 2, 2018. The investigators were Emilie Kahn and Emily J. Orban. Most observations concern quality system and production; the most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit).

At a glance

Quality system and production account for 2 of 2 observations.

Quality system1
Production1

Most cited: 21 CFR 211.22(d) (1×) · 211.188(b) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    The responsibilities and procedures applicable to the quality control unit…

  2. 02

    The batch production and control records are deficient in that they do not include documentation of…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Lannett Company, Inc.?

FDA listed 2 observations on this Form 483, mostly about quality system and production. The most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit). The opening words of each observation are shown on this page.

Who inspected Lannett Company, Inc.?

Emilie Kahn and Emily J. Orban are named on this Form 483, for the inspection of Jan 29 – Feb 2, 2018. Each investigator has a profile showing what they cite most.

When was Lannett Company, Inc. inspected by FDA?

The inspection ran Jan 29 – Feb 2, 2018, and the Form 483 is dated February 2, 2018.

How do I get the full Form 483 for Lannett Company, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free